FDA Commissioner Robert M. Califf has said that advances in gene knowledge could lead to gene-editing for the cure of diseases. The relatively recent advances in data sharing and genomic study will allow for precision medical therapies, Califf said in his keynote address to the “Improving Clinical Research in the Age of Precision Medicine” symposium on the last 10 years. The ability of gene editing to remove or replace genes that cause diseases could be used in the near future for genetic-related illnesses, such as sickle cell disease, which has been treated successfully in mice using a genetically-engineered virus.
FDA Commissioner Robert M. Califf has said that advances in gene knowledge could lead to gene-editing for the cure of diseases. The relatively recent advances in data sharing and genomic study will allow for precision medical therapies, Califf said in his keynote address to the “Improving Clinical Research in the Age of Precision Medicine” symposium on 14-15 September. The ability of gene editing to remove or replace genes that cause diseases could be used in the near future for genetic-related illnesses, such as sickle cell disease, which has been treated successfully in mice using a genetically-engineered virus.